On April 19, 2018, Partner Stephen Goodman, Co-Chair of Pryor Cashman's Life Sciences Group, will moderate a panel at the BioMEDevice Boston Conference. Goodman, who is also co-founder of Mid Atlantic Bio Angels - a life science angel investor group - and his fellow panelists will explore how to seek out investors, the different views of angel groups and venture capital investors in evaluating investment opportunities, and the pros and cons of working with angels.
To learn more about this event, or to register, please visit here.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.